JULIA FITZMORRIS: Open Payments
NPI 1932853454 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 23 payments from 7 companies in 2025. Trend: 2023 $251 · 2024 $258 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $141 |
| Evofem Biosciences, Inc. | 9 | $58 |
| CooperSurgical, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| PFIZER INC. | 1 | $27 |
| Organon LLC | 1 | $15 |
| Dilon Technologies, Inc. | 1 | $15 |
Products named: Veozah, Phexxi, Paragard T 380A, Mirena, COMIRNATY, JADA SYSTEM, HEMOBLAST BELLOWS.
Industry payments across LA — which companies pay providers there.
